Aurobindo Pharma reported 25.06B in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Cipla CIPLA:IN 21.37B 678.5M
Dr.Reddys Laboratories DRRD:IN 20.28B 3.26B
Hindustan Unilever HUVR:IN IR 63210M 2760M
Sun Pharmaceuticals SUNP:IN IR 25218.6M 1275.7M
UPL UPLL:IN 52.21B 15.18B